NHRC Advocates for Change to Naloxone’s Drug Status

In late November, National Harm Reduction Coalition (NHRC) joined policy advocates from across the country in submitting joint comments in response to the U.S. Food and Drug Administration (FDA) proposed rule which would create a new category of medication – between prescription and non-prescription – called “nonprescription drug product with an additional condition for nonprescription … NHRC Advocates for Change to Naloxone’s Drug Status